JP2012524772A5 - - Google Patents

Download PDF

Info

Publication number
JP2012524772A5
JP2012524772A5 JP2012506584A JP2012506584A JP2012524772A5 JP 2012524772 A5 JP2012524772 A5 JP 2012524772A5 JP 2012506584 A JP2012506584 A JP 2012506584A JP 2012506584 A JP2012506584 A JP 2012506584A JP 2012524772 A5 JP2012524772 A5 JP 2012524772A5
Authority
JP
Japan
Prior art keywords
composition
triglycerides
omega
pharmaceutical composition
buccal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012506584A
Other languages
English (en)
Japanese (ja)
Other versions
JP5795760B2 (ja
JP2012524772A (ja
Filing date
Publication date
Priority claimed from PCT/GB2009/050415 external-priority patent/WO2010122275A1/en
Priority claimed from GB0906971.7A external-priority patent/GB2469791B/en
Application filed filed Critical
Priority claimed from PCT/GB2010/050672 external-priority patent/WO2010122356A1/en
Publication of JP2012524772A publication Critical patent/JP2012524772A/ja
Publication of JP2012524772A5 publication Critical patent/JP2012524772A5/ja
Application granted granted Critical
Publication of JP5795760B2 publication Critical patent/JP5795760B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012506584A 2009-04-23 2010-04-23 ジヒドロアルテミシニンを含む舌下スプレー用製剤 Expired - Fee Related JP5795760B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBPCT/GB2009/050415 2009-04-23
PCT/GB2009/050415 WO2010122275A1 (en) 2009-04-23 2009-04-23 Pharmaceutical preparation
GB0906971.7 2009-04-23
GB0906971.7A GB2469791B (en) 2009-04-23 2009-04-23 Transmucosal formulation of compounds providing dihydroartemesinin for use in the treatment of neoplastic disease
PCT/GB2010/050672 WO2010122356A1 (en) 2009-04-23 2010-04-23 Sublingual spray formulation comprising dihydroartemesinin

Publications (3)

Publication Number Publication Date
JP2012524772A JP2012524772A (ja) 2012-10-18
JP2012524772A5 true JP2012524772A5 (OSRAM) 2013-05-02
JP5795760B2 JP5795760B2 (ja) 2015-10-14

Family

ID=42244197

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012506584A Expired - Fee Related JP5795760B2 (ja) 2009-04-23 2010-04-23 ジヒドロアルテミシニンを含む舌下スプレー用製剤

Country Status (23)

Country Link
US (4) US20120157518A1 (OSRAM)
EP (1) EP2424523B1 (OSRAM)
JP (1) JP5795760B2 (OSRAM)
CN (1) CN102395362B (OSRAM)
AU (1) AU2010240654C1 (OSRAM)
BR (1) BRPI1014887A8 (OSRAM)
CA (1) CA2756925A1 (OSRAM)
DK (1) DK2424523T3 (OSRAM)
ES (1) ES2390046T3 (OSRAM)
HR (1) HRP20120711T1 (OSRAM)
IL (1) IL215453A (OSRAM)
ME (1) ME02008B (OSRAM)
MX (1) MX2011010961A (OSRAM)
MY (1) MY155646A (OSRAM)
NZ (1) NZ595469A (OSRAM)
PL (1) PL2424523T3 (OSRAM)
PT (1) PT2424523E (OSRAM)
RS (1) RS52430B (OSRAM)
RU (1) RU2501550C2 (OSRAM)
SG (1) SG175162A1 (OSRAM)
SI (1) SI2424523T1 (OSRAM)
WO (1) WO2010122356A1 (OSRAM)
ZA (1) ZA201107088B (OSRAM)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0720967D0 (en) * 2007-10-25 2007-12-05 Protophama Ltd Anti-material pharmaceutical composition
EP2421503A1 (en) * 2009-04-23 2012-02-29 Londonpharma Ltd. Sublingual pharmaceutical composition comprising a neutral oil
JP6513576B2 (ja) * 2013-01-14 2019-05-15 ヘルス クリニックス リミテッド 抗がん剤および使用
WO2016083827A1 (en) 2014-11-27 2016-06-02 Cipla Limited Pharmaceutical composition comprising an artemisinin derivative for nasal or pulmonary delivery
JP2020033304A (ja) * 2018-08-30 2020-03-05 医療法人ふじいやさか 薬剤又はサプリメント、組成物、及び水素供給器の使用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030082107A1 (en) * 1997-10-01 2003-05-01 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating an infectious disease or cancer
CH692321A5 (de) * 1997-11-03 2002-05-15 Mepha Ag Pharmazeutisch wirksame Zusammensetzung, welche eine gegen Malariaparasiten wirksame Substanz enthält.
TR200100073T2 (tr) * 1998-07-14 2001-05-21 Bayer Aktiengeselkschaft Antiparazitik artemisinin türevleri (endoperoksitler)
US20040092583A1 (en) * 2001-01-02 2004-05-13 Elizabeth Shanahan-Prendergast Treatment for inhibiting neoplastic lesions
AU2003240824B9 (en) * 2002-05-31 2008-09-25 University Of Mississippi Transmucosal delivery of cannabinoids
RU2004139090A (ru) * 2002-06-06 2005-06-10 Юниверсити Оф Вашингтон (Us) Способы применения соединений, подобных артемизинину, для профилактики или задержки возникновения злокачественных опухолей
WO2004075921A1 (en) * 2003-02-26 2004-09-10 Vrije Universiteit Brussel Inclusion complex of artemisinin or derivates thereof with cyclodextrins
US20060084675A1 (en) * 2004-10-18 2006-04-20 Thomas Efferth Combined treatment with artesunate and an epidermal growth factor receptor kinase inhibitor
US20060233895A1 (en) * 2005-04-15 2006-10-19 Brown Paul R Herbal remedy for treating Lyme disease
JP5362360B2 (ja) * 2005-10-11 2013-12-11 イッサム リサーチ ディヴェロップメント カンパニー オブ ザ ヘブリュー ユニバーシティー オブ エルサレム 経鼻投与用組成物
CN100418524C (zh) * 2005-10-26 2008-09-17 重庆医药工业研究院有限责任公司 一种稳定的青蒿素及青蒿素衍生物的药物组合物

Similar Documents

Publication Publication Date Title
JP2022180461A5 (OSRAM)
JP2011500781A5 (OSRAM)
JP5822991B2 (ja) 毒性を減少し、そして疾病を治療又は予防するための化合物、組成物及び方法
JP2013511496A5 (OSRAM)
ES2564936T3 (es) Aerosol nasal líquido que contiene naltrexona a dosis baja
JP2015528491A5 (OSRAM)
AR065579A1 (es) Mejoras en composiciones medicinales o relativas a las mismas
JP2016517434A5 (OSRAM)
EA200802012A1 (ru) Фармацевтические препараты в форме раствора для дозирующих ингаляторов под давлением
JP2013542247A5 (OSRAM)
NZ605887A (en) Pharmaceutical dosage form comprising 6’-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4’,9’-dihydro-3’h-spiro[cyclohexane-1,1’-pyrano[3,4,b]indol]-4-amine for the treatment of neuropathic pain
JP2014515373A5 (OSRAM)
JP2012524772A5 (OSRAM)
HRP20140592T1 (hr) Poboljšani medicinski pripravci koji sadrže buprenorfin i naltrekson
WO2007012019A3 (en) Medicaments containing famotidine and ibuprofen and administration of same
WO2017092230A1 (zh) 双黄酮化合物及其治疗癌症和制备药物的用途
RU2011139637A (ru) Сублингвальная спреевая композиция, содержащая дигидроартемизинин
JP2015507020A5 (OSRAM)
JP2013523740A5 (OSRAM)
JP2016505050A5 (OSRAM)
WO2015009731A3 (en) Azacyclic constrained analogs of fty720
RU2012108144A (ru) Противораковая терапия, направленная против раковых стволовых клеток и форм рака, устойчивых к лечению лекарственными препаратами
US20220305223A1 (en) Olfactory Delivery Device, System and Method for the Delivery of a Variety of Pharmaceutical Agents
CN104869986A (zh) 用于癌症的组合疗法
JP2017514829A5 (OSRAM)